May issue includes: AMCP Submits Comments on Proposed Part D MTM Program CMR Changes; AMCP Submits Comments on Proposed Part D MTM Program CMR Changes; Two Proposed Biosimilars Bills Fail to Advance
April issue includes: CARES Act Includes Changes Relevant to Managed Care Pharmacy, Substance Abuse Record Rules; HHS Authorizes Pharmacists to Order and Administer COVID19 Tests; AMCP Launches COVID19 Resource Center; AMCP Submits Comments on Proposed Medicare Advantage and Part D Rule; AMCP Comments to FDA and FTC on a Competitive Biosimilar Marketplace
June 2020 News & Views includes: ACHP/AMCP Survey Finds COVID-19 Has Shifted Consumer Behavior; Confidence in Pharmacies Remains High; AMCP Joins Peers in Promoting Patient Access to Rx Drugs; Cantrell Participates in PQA Fireside Chat to Describe how Managed Care Pharmacy Is Addressing the Pandemic; Univ. of California, San Francisco School of Pharmacy Wins AMCP Foundation’s 20th Annual P&T Competition; AMCP Foundation Awards Best Posters for Research on Opioid Use, Migraine Therapy, and Preterm Births; New AMCP Resource Focuses on Atherosclerotic Cardiovascular Disease
On June 1, 2020, the FDA issued a RFI requesting stakeholder comments on updating and improving the Orange Book. Please send any feedback to advocacy@amcp.org by August 14, 2020.
